🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/12/1987 | 8,36 | 8,57 | 8,27 | 8,53 | +2,38% | 3,57% | 16.121.174 |
| 17/12/1987 | 8,56 | 8,57 | 8,30 | 8,34 | -2,33% | 3,17% | 8.805.715 |
| 16/12/1987 | 8,38 | 8,53 | 8,11 | 8,53 | +1,42% | 5,06% | 13.721.674 |
| 15/12/1987 | 8,58 | 8,59 | 8,38 | 8,42 | -1,24% | 2,47% | 10.758.139 |
| 14/12/1987 | 8,35 | 8,52 | 8,34 | 8,52 | +2,39% | 2,22% | 9.343.339 |
| 11/12/1987 | 8,40 | 8,51 | 8,32 | 8,32 | -1,26% | 2,21% | 7.200.389 |
| 10/12/1987 | 8,38 | 8,75 | 8,32 | 8,43 | -1,39% | 5,06% | 12.627.562 |
| 09/12/1987 | 8,36 | 8,69 | 8,36 | 8,55 | +1,74% | 4,04% | 10.435.565 |
| 08/12/1987 | 8,34 | 8,40 | 8,10 | 8,40 | +0,32% | 3,65% | 10.552.522 |
| 07/12/1987 | 8,22 | 8,38 | 8,19 | 8,38 | +2,93% | 2,26% | 9.997.920 |
| 04/12/1987 | 8,38 | 8,46 | 8,11 | 8,14 | -4,06% | 4,11% | 15.255.317 |
| 03/12/1987 | 9,03 | 9,05 | 8,48 | 8,48 | -5,81% | 6,31% | 11.361.787 |
| 02/12/1987 | 8,96 | 9,06 | 8,91 | 9,01 | +0,82% | 1,77% | 7.417.325 |
| 01/12/1987 | 9,09 | 9,09 | 8,93 | 8,93 | -0,88% | 1,75% | 10.363.882 |
| 30/11/1987 | 9,08 | 9,22 | 8,92 | 9,01 | -3,13% | 3,36% | 13.431.168 |
| 27/11/1987 | 9,42 | 9,45 | 9,30 | 9,30 | -1,82% | 1,55% | 3.063.514 |
| 25/11/1987 | 9,48 | 9,52 | 9,44 | 9,48 | +0,14% | 0,84% | 6.119.482 |
| 24/11/1987 | 9,28 | 9,52 | 9,24 | 9,46 | +2,96% | 3,00% | 10.633.637 |
| 23/11/1987 | 9,06 | 9,20 | 9,05 | 9,19 | +0,58% | 1,61% | 7.760.650 |
| 20/11/1987 | 8,93 | 9,16 | 8,91 | 9,14 | +1,17% | 2,82% | 14.202.706 |
| 19/11/1987 | 9,05 | 9,17 | 8,94 | 9,03 | -0,37% | 2,56% | 11.405.174 |
| 18/11/1987 | 9,10 | 9,13 | 8,85 | 9,06 | +0,44% | 3,06% | 9.437.659 |
| 17/11/1987 | 9,18 | 9,20 | 9,01 | 9,03 | -2,58% | 2,02% | 9.194.314 |
| 16/11/1987 | 9,48 | 9,48 | 9,18 | 9,26 | -0,36% | 3,08% | 9.398.045 |
| 13/11/1987 | 9,53 | 9,57 | 9,28 | 9,30 | -2,57% | 3,06% | 10.958.098 |
| 12/11/1987 | 9,60 | 9,60 | 9,45 | 9,54 | +1,91% | 1,52% | 13.042.570 |
| 11/11/1987 | 9,32 | 9,41 | 9,32 | 9,36 | +1,58% | 1,00% | 7.460.712 |
| 10/11/1987 | 9,03 | 9,33 | 8,96 | 9,22 | +0,36% | 4,11% | 15.734.462 |
| 09/11/1987 | 9,25 | 9,30 | 9,12 | 9,18 | -3,21% | 2,01% | 14.493.211 |
| 06/11/1987 | 9,78 | 9,81 | 9,44 | 9,49 | -2,19% | 3,79% | 10.437.451 |